Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Priester

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Vaccines|March 28, 2024
Long-Term Immunological Alertness and Response to COVID-19 Vaccination-Conditions for Prevention in Early Palliative Oncological Care PatientsPeter Priester, Miroslav Fajfr, Veronika Molnarova, et al.
Clinical & Experimental Metastasis|August 2, 2025
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Petr Hošek, Michaela Tkadlecová, et al.
In Vivo (Athens, Greece)|February 27, 2026
The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With NivolumabOndrej Fiala, Michaela Tkadlecova, Jindrich Kopecky, et al.
Scientific Reports|July 5, 2026
Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Tomas Buchler, Alexandr Poprach, et al.
Scientific Reports|December 21, 2025
Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Katarína Rejleková, Tomas Buchler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Vaccines|March 28, 2024
Long-Term Immunological Alertness and Response to COVID-19 Vaccination-Conditions for Prevention in Early Palliative Oncological Care PatientsPeter Priester, Miroslav Fajfr, Veronika Molnarova, et al.
Clinical & Experimental Metastasis|August 2, 2025
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Petr Hošek, Michaela Tkadlecová, et al.
In Vivo (Athens, Greece)|February 27, 2026
The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With NivolumabOndrej Fiala, Michaela Tkadlecova, Jindrich Kopecky, et al.
Scientific Reports|July 5, 2026
Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Tomas Buchler, Alexandr Poprach, et al.
Scientific Reports|December 21, 2025
Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Katarína Rejleková, Tomas Buchler, et al.
Pageof 2